Avalo Therapeutics stockAVTX
Avalo Therapeutics trades at $6.63, 72.7% below its 52-week high (May 7, 2026). The price is below its 50- and 200-day averages, a downtrend. −63.5% year to date, −59.7% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 5, 2026.
Ratings, candles, signals and the screener for AVTX — after you log in
Open the terminalFrequently asked questions about Avalo Therapeutics
What is the Avalo Therapeutics stock price?
At the close on Nov 5, 2026: $6.63 (−6.22% on the day). 52-week high: $24.27 on May 7, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Avalo Therapeutics report earnings?
The next quarterly report is on Nov 5, 2026. Last quarter, earnings per share changed +84% year over year, revenue 0%.
Does Avalo Therapeutics pay dividends?
No, Avalo Therapeutics does not pay dividends.
Where does Avalo Therapeutics trade and how to buy it?
Ticker AVTX, exchange Nasdaq, listed since 2015. You can buy it through a broker with access to US exchanges.
Should I buy Avalo Therapeutics now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for AVTX are in the terminal after you log in.